 |
141 Diseases |  |
27 Trials |
|
27 Trials |  |
1501 News |  |
| «1234567891011 |
- prednisone / Generic mfg., docetaxel / Generic mfg., cabazitaxel / Generic mfg.
New P2 trial: Cabazitaxel Plus Prednisone With Octreotide For Castration-Resistant Prostate Cancer (CRPC) Previously Treated With Docetaxel (clinicaltrials.gov) - Nov 8, 2011
P2, N=50, Recruiting, Sponsor: University of Southern California
- |||| Sandostatin LAR Depot (octreotide acetate) / Novartis
Trial completion: POTA: Preoperative Octreotide Treatment of Acromegaly (clinicaltrials.gov) - Oct 19, 2011
P4, N=62, Completed, Sponsor: St. Olavs Hospital
Active, not recruiting --> Completed
- | tamoxifen / Generic mfg.
Enrollment change: Tamoxifen With or Without Octreotide in Treating Postmenopausal Women With Stage I, Stage II, or Stage III Breast Cancer (clinicaltrials.gov) - Sep 12, 2011
P3, N=667, Completed, Sponsor: NCIC Clinical Trials Group
Active, not recruiting --> Completed N=850 --> 667
- | octreotide acetate / Generic mfg.
New P4 trial: Effects of Sandostatin LAR (clinicaltrials.gov) - Aug 24, 2011
P4, N=20, Active, not recruiting, Sponsor: Columbia University
- midodrine hydrochloride / Generic mfg., octreotide acetate / Generic mfg.
Trial completion: Vasoconstrictors as Alternatives to Albumin After Large-Volume Paracentesis (LVP) in Cirrhosis (clinicaltrials.gov) - Aug 16, 2011
P4, N=29, Completed, Sponsor: Department of Veterans Affairs
N=850 --> 667 Active, not recruiting --> Completed